Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress

prnewswireOctober 29, 2020

Tag: Ampio , COVID-19 , Clinical Trial

PharmaSources Customer Service